Advertisement

Benzodiazepine Receptor Subtypes and Their Possible Clinical Significance

  • W. Sieghart
Conference paper
Part of the Psychopharmacology Series book series (PSYCHOPHARM, volume 7)

Abstract

Benzodiazepines such as diazepam, flunitrazepam or bromazepam belong to the most widely prescribed drugs in current therapeutic use because of their anxiolytic, anticonvulsant, muscle-relaxant and hypnotic effects. A large number of electrophysiological investigations indicate that benzodiazepines enhance the actions of γ-aminobutyric acid (GABA) on its receptor (Haefely et al. 1981). GABA is the quantitatively most important inhibitory neurotransmitter in the mammalian CNS. Approximately 30% of all synapses in the brain are estimated to be GABAergic. Since this GABA-enhancing effect was found in many different physiological systems, it is now generally assumed that benzodiazepines produce most of their actions by modulating the GABAergic system (Tallman et al. 1980).

Keywords

Primary Central Nervous System Tumour Flunitrazepam Binding Zodiazepine Receptor Flunitrazepam Binding Site Human Primary Central Nervous System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barnard EA, Stephenson FA, Sigel E, Mamalaki C, Bilbe G, Constanti A, Smart TE, Brown DA (1984) Structure and properties of the brain GABA/benzodiazepine receptor com-plex. In: Kito S, Segawa T, Kuriyama K, Yamamura HI, Olsen RW (eds) Neurotrans-mitter receptors: mechanisms of action and regulation. Plenum, New York, pp 235–254Google Scholar
  2. Bowling AC, de Lorenzo RJ (1982) Micromolar affinity benzodiazepine receptors identification and characterization in central nervous system. Science 216: 1247–1250Google Scholar
  3. Braestrup C, Nielsen MJ (1983) Benzodiazepine receptors. In: Iversen L, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 17. Plenum, New York, pp 285–384Google Scholar
  4. Braestrup C, Squires R (1977) Specific benzodiazepine receptors in rat brain characterized by high affinity [3H]-diazepam binding. Proc Natl Acad Sci USA 74: 3804–3809CrossRefGoogle Scholar
  5. Eichinger A, Sieghart W (1984) Photoaffinity labeling of different benzodiazepine receptors at physiological temperature. J Neurochem 43: 1745–1748PubMedCrossRefGoogle Scholar
  6. Fuchs K, Möhler H, Sieghart W (1988) Various proteins from rat brain, specifically and irreversibly labeled by [3H]-flunitrazepam are distinct a-subunits of the GABA- benzodiazepine receptor complex. Neurosci Lett 90: 314–319PubMedCrossRefGoogle Scholar
  7. Fuchs K, Sieghart W (1989) Evidence for the existence of several different α- and β-subunits of the GABA/benzodiazepine receptor complex from rat brain. Neurosci Lett 97: 329–333PubMedCrossRefGoogle Scholar
  8. Gee KW, Yamamura HI (1982) Regional heterogeneity of benzodiazepine receptors at 37 °C: an in vitro study in various regions of the rat brain. Life Sci 31: 1939–1945PubMedCrossRefGoogle Scholar
  9. Haefely W, Pole P (1986) Physiology of GAB A enhancement by benzodiazepines and bar-biturates. In: Olsen RW, Venter JC (eds) Benzodiazepine-GABA receptors and chloride channels; structure and functional properties. Liss, New York, pp 97–133Google Scholar
  10. Haefely W, Pieri L, Pole P, Schaffner R (1981) General pharmacology and neuropharmacology of benzodiazepine derivatives. In: Hoffmeister E, Stille G (eds) Handbook of experimental pharmacology, vol 55/11. Springer, Berlin Heidelberg New York, p 134Google Scholar
  11. Haefely W, Kyburz E, Gerecke M, Möhler H (1985) Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure-activity relationships of their agonists and antagonists. Adv Drug Res 14: 167–322Google Scholar
  12. Iorio LC, Barnett A, Billard W (1984) Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type I receptor sites. Life Sci 35: 105–114PubMedCrossRefGoogle Scholar
  13. Johansen J, Taft WC, Yang J, Kleinhaus AL, de Lorenzo RJ (1985) Inhibition of Ca+ + conductance in identified leech neurons by benzodiazepines. Proc Natl Acad Sci USA 82: 3935–3939Google Scholar
  14. Klepner CA, Lippa AS, Benson DI, Sano MC, Beer B (1979) Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol Biochem Behav 11: 457–462PubMedCrossRefGoogle Scholar
  15. Lippa AS, Jackson D, Wennogle LP, Beer B, Meyerson LR (1982) Non-benzodiazepine agonists for benzodiazepine receptors. In: Usdin E, Skolnick P, Tallman JF, Greenblatt D, Paul SM (eds) Pharmacology of benzodiazepines. Macmillan, London, pp 431–440Google Scholar
  16. Maziere M, Hantraye P, Kaijima M, Dodd R, Guibert B, Prenant C, Sastre J, et al. (1985) Visualization by positron emission tomography of the apparent regional heterogeneity of central type benzodiazepine receptors in the brain of living baboons. Life Sci 36: 1609–1616PubMedCrossRefGoogle Scholar
  17. Mestre M, Belin C, Uzan A, Renault C, Dubroeucq MC, Gueremy C, Le Fur G (1986) Modulation of voltage operated, but not receptor operated, calcium channels in the rabbit aorta by PK 111 95, an antagonist of peripheral-type benzodiazepine receptors. J Cardiovasc Pharmacol 8: 729–734PubMedGoogle Scholar
  18. Möhler H, Okada T (1977) Benzodiazepine receptors - demonstration in the central nervous system. Science 198: 849–851PubMedCrossRefGoogle Scholar
  19. Morgan JI, Johnson MD, Wang JKT, Sonnenfeld KH, Spector S (1985) Peripheral type benzodiazepines influence ornithinedecarboxylase levels and neurite outgrowth in PC 12 cells. Proc Natl Acad Sci USA 82: 5223–5226PubMedCrossRefGoogle Scholar
  20. Olsen RW (1982) Drug interactions at the GABA receptor ionophore complex. Annu Rev Pharmacol Toxicol 22: 245–277PubMedCrossRefGoogle Scholar
  21. Sarter M, Schneider HH, Stephens DN (1988) Treatment strategies for senile dementia: antagonist β-carbolines. Trends Neurosci 11: 13–16PubMedCrossRefGoogle Scholar
  22. Schoemaker H, Bliss M, Yamamura HI (1981) Specific high affinity binding of [3H]-Ro 5- 4864 to benzodiazepine binding sites in rat cerebral cortex. Eur J Pharmacol 71: 173–175PubMedCrossRefGoogle Scholar
  23. Sieghart W (1988) Comparison of two different benzodiazepine binding proteins by peptide mapping after limited proteolysis. Brain Res 450: 387–391PubMedCrossRefGoogle Scholar
  24. Sieghart W, Karobath M (1980) Molecular heterogeneity of benzodiazepine receptors. Nature 286: 285–287PubMedCrossRefGoogle Scholar
  25. Sieghart W, Schuster A (1984) Affinity of various ligands for benzodiazepine receptors in rat cerebellum and hippocampus. Biochem Pharmacol 33: 4033–4038PubMedCrossRefGoogle Scholar
  26. Sieghart W, Mayer A, Drexler G (1983) Properties of [3H]-flunitrazepam binding to different benzodiazepine binding proteins. Eur J Pharmacol 88: 291–299PubMedCrossRefGoogle Scholar
  27. Sieghart W, Eichinger A, Zezula J (1987) Comparison of tryptic peptides of benzodiazepine binding proteins photolabeled with [3H]-flunitrazepam or [3H]-Ro 15-4513. J Neurochem 48: 1109–1114PubMedCrossRefGoogle Scholar
  28. Sigel E, Stephenson FA, Mamalaki C, Barnard E (1983) A γ-aminobutyric acid/benzodiazepine receptor complex of bovine cerebral cortex. Purification and partial characterization. J Biol Chem 258: 6965–6971PubMedGoogle Scholar
  29. Stapleton SR, Prestwich SA, Horton RW (1982) Regional heterogeneity of benzodiazepine binding sites in rat brain. Eur J Pharmacol 84: 221PubMedCrossRefGoogle Scholar
  30. Starosta-Rubinstein S, Ciliax BJ, Penney JB, McKeever P, Young AB (1987) Imaging of a glioma using peripheral benzodiazepine receptor ligands. Proc Natl Acad Sci USA 84: 891–895PubMedCrossRefGoogle Scholar
  31. Tallman JF, Paul SM, Skolnick P, Gallager DW (1980) Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science 207: 274–281PubMedCrossRefGoogle Scholar
  32. Wilkinson M, Grovestine D, Hamilton JT (1982) Flunitrazepam binding sites in rat diaphragm. Receptors for direct neuromuscular effects of benzodiazepines? Can J Physiol Pharmacol 60: 1003–1005PubMedCrossRefGoogle Scholar
  33. Zavala F, Haumont J, Lenfant M (1984) Interaction of benzodiazepines with mouse macrophages. Eur J Pharmacol 106: 561–566PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • W. Sieghart
    • 1
  1. 1.Department of Biochemical PsychiatryPsychiatrische UniversitätsklinikWienAustria

Personalised recommendations